Liposomal bupivacaine infiltration associated with lower pain and narcotic use after RC repair .
Liposomal bupivacaine reduces opiate consumption after rotator cuff repair in a randomized controlled trial
J Shoulder Elbow Surg. 2019 May;28(5):819-827. doi: 10.1016/j.jse.2019.01.00855 patients scheduled for arthroscopic repair of a full-thickness rotator cuff tear were randomized to a multimodal analgesia regimen with or without the addition of intraoperative liposomal bupivacaine infiltration. Patients were assessed for daily pain scores and narcotic consumption over the first 5 days after surgery. Results demonstrated significantly lower pain scores for the first 2 days postoperatively, and significantly lower narcotic consumption over the first 5 days after surgery, in the liposomal bupivacaine group compared to the control group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
